La vendita allo scoperto per Molecular Partners dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Molecular Partners. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Molecular Partners (NASDAQ:MOLN) Azioni, Report sulle vendite allo scoperto

Molecular Partners

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Molecular Partners AG - American Depositary Shares

Molecular Partners AG

STRZ

Trading Halt: Halt status updated at 9:40:00 AM ET: Quotation Resumption: New Issue Available

Wells Fargo analyst Neil Kalton maintains WEC Energy Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>) with a Overweight and raises the price target from $115 to $124.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on WEC Energy Group, Raises Price Target to $124

New York Times Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYT#NYSE">NYT</a>) reported financial results for the first quarter before the market open on Wednesday. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/05/b45248204/the-new-york-times-company-reports-first-quarter-2025-results">of the report</a>.
Q1 Earnings: New York Times reported first-quarter revenue of $636 million, beating analyst <a href="http://benzinga.com/quote/NYT/earnings">estimates</a> of $634.83 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported first-quarter adjusted earnings of 41 cents per share, beating estimates of 34 cents per share. 
Total revenue was up 7.1% on a year-over-year basis. Here&#8217;s a breakdown of revenue by category.
<ul>
<li>Subscription revenue: $464.3 million, up 8.2%</li>
</ul>
<ul>
<li>Advertising revenue: $108.1 million, up 4.2%</li>
</ul>
<ul>
<li>Affiliate, Licensing and Other revenue: $63.6 million, up 3.7%</li>
</ul>
New York Times ended the period with approximately 11.66 million subscribers to print and digital products. 11.06 million of those subscribers were digital-only subscribers, which includes 5.76 million bundle and multi product subscribers. Total digital-only subscribers were up 1.15 million from the prior year&#8217;s quarter. Average revenue per user (ARPU) was $9.54 in the first quarter, up 3.6% year-over-year. 
The company ended the quarter with $902.3 million in cash and marketable securities. 
&#8220;As our first quarter results show, we&#8217;ve had a strong start to the year. Our strategy is working and our business is growing and demonstrating resilience amidst the current economic and geopolitical uncertainty,&#8221; said Meredith Kopit Levien, president and CEO of New York Times.
Check This Out: <a href="https://www.benzinga.com/25/04/45084812/readers-correctly-predicted-tesla-earnings-heres-their-view-on-apple-stock">Readers Correctly Predicted Tesla Earnings – Here&#8217;s Their View On Apple Stock</a>
New York Times repurchased approximately $58.9 million of its common stock in the quarter. The company had $443 million remaining under its buyback as of May 2.
Guidance: New York Times expects second-quarter digital-only subscription revenue to grow between 13% and 16% year-over-year. The company expects total subscription revenue growth of 8% to 10% in the second quarter. 
Digital advertising revenue is expected to increase in the high-single-digits, while total advertising revenue is expected to be flat to up in the low-single-digits. The company also guided for affiliate, licensing and other revenue growth in the mid-single-digits in the second quarter.
NYT Price Action: <a href="http://benzinga.com/quote/NYT">New York Times shares</a> were down 1.1% at $52.02 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45183831/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-63">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/tadaimages">Tada Images</a>/Shutterstock.

Earnings

Guidance

Movers

New York Times Q1 Earnings: Revenue Beat, EPS Beat, Business Is Showing 'Resilience' Amid 'Uncertainty'

Wells Fargo analyst Neil Kalton maintains Duke Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) with a Overweight and raises the price target from $127 to $138.

Wells Fargo Maintains Overweight on Duke Energy, Raises Price Target to $138

HC Wainwright &amp; Co. analyst Andrew Fein maintains Denali Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNLI#NASDAQ">DNLI</a>) with a Buy and lowers the price target from $80 to $32.

DNLI

HC Wainwright & Co. Maintains Buy on Denali Therapeutics, Lowers Price Target to $32

Wells Fargo analyst Neil Kalton maintains American Electric Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) with a Equal-Weight and raises the price target from $107 to $114.

Wells Fargo Maintains Equal-Weight on American Electric Power, Raises Price Target to $114

WIIM

RARE

RARE stock has given up its prior gain. Ultragenyx Pharmaceutical shares were trading higher after the company reported better-than-expected Q1 EPS results.

Wells Fargo analyst Michael Blum maintains Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) with a Overweight and lowers the price target from $22 to $21.

Wells Fargo Maintains Overweight on Energy Transfer, Lowers Price Target to $21

Wallbox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBX#NYSE">WBX</a>) sees Q2 sales of $38.909 million-$41.013 million vs $40.90 million analyst estimate.

Wallbox Sees Q2 Sales $38.909M-$41.013M vs $40.90M Est

On May&nbsp;6, 2025, the Company announced a strategic plan (the "Plan") to evolve its operations to yield greater efficiencies as the Company continues to scale its business with focus and discipline to meet its goal of $10 billion in ending ARR. The Plan is expected to result in a reduction of roles representing approximately 500 positions or 5% of the Company's global workforce. CrowdStrike expects to continue to hire in key strategic areas throughout its fiscal year ending January&nbsp;31, 2026.
&nbsp;
CrowdStrike estimates that it will incur approximately $36 million to $53 million in charges in connection with the Plan, of which approximately $7 million is expected to be recognized in the first quarter of fiscal 2026, and substantially all of the remainder of which will be incurred in the second quarter of fiscal 2026. These charges primarily consist of approximately $19 million to $26 million of future cash expenditures related to severance payments, employee benefits, and related costs; and approximately $10 million to $20 million in non-cash charges for stock-based compensation. The Company intends to exclude the charges associated with the Plan from its non-GAAP financial measures.

Management

CRWD

CrowdStrike Unveils Strategic Plan To Drive Operational Efficiency And Support $10B ARR Goal, Cutting 5% Of Global Workforce And Incurring Up To $53M In Restructuring Charges While Continuing To Hire In Key Growth Areas

Trulieve Cannabis Corp (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTCQX">TCNNF</a>) reported first-quarter financial results ahead of the market open on Wednesday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/05/n45246817/trulieve-reports-first-quarter-2025-results-demonstrating-core-business-strength">from the quarter</a>.
Q1 Earnings: Trulieve reported first-quarter revenue of $297.8 million, beating analyst&nbsp;<a href="http://benzinga.com/quote/tcnnf/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $294.4 million, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The cannabis company reported a first-quarter adjusted loss of 2 cents per share, beating estimates for a loss of 8 cents per share.
Total revenue &#8220;increased slightly&#8221; on a year-over-year basis, with 95% of revenue coming from retail sales. Trulieve reported a first-quarter gross margin of 62%, up from 58% last year. 
The company generated $51 million in cash flow from operations and free cash flow of $34 million in the first quarter. Trulieve ended the quarter with $329 million in cash.
&#8220;Strong margins and cash flow achieved in the&nbsp;first quarter&nbsp;clearly demonstrate our commitment to operational excellence. With our loyal customer base, branded products, and efforts to drive cannabis reform, Trulieve stands out as an industry leader,&#8221; said&nbsp;Kim Rivers, CEO of Trulieve.
Reward program members climbed to over 625,000 during the period. Trulieve added one new dispensary in St. Petersburg,&nbsp;Florida, increasing its retail footprint to 229 locations at quarter&#8217;s end.
Trulieve executives discussed the quarter on a call with investors and analysts that got started at 8:30 a.m. ET.
TCNNF Price Action:&nbsp;<a href="http://benzinga.com/quote/tcnnf" target="_blank" rel="noreferrer noopener">Trulieve Cannabis shares</a>&nbsp;were trading at $4.47 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/25/05/45228483/desantis-signs-new-petition-law-that-could-block-marijuana-ballot-campaignlawsuit-challenges-constitutionality">DeSantis Signs New Petition Law That Could Block Marijuana Ballot Campaign—Lawsuit Challenges Constitutionality</a></li>
</ul>
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/45113866/donald-trumps-dea-nominee-reviewing-cannabis-rescheduling-will-be-one-of-my-first-priorities">Donald Trump&#8217;s DEA Nominee: Reviewing Cannabis Rescheduling Will &#8216;Be One Of My First Priorities&#8217;</a></li>
</ul>
Photo: courtesy of Trulieve.

Cannabis

TCNNF

Trulieve Q1 Earnings: Revenue, EPS Beat Estimates On 'Strong' Margins, Cash Flow

Wells Fargo analyst Michael Blum maintains SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) with a Equal-Weight and lowers the price target from $19 to $15.

SEDG

Wells Fargo Maintains Equal-Weight on SolarEdge Technologies, Lowers Price Target to $15

Immunocore Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.39) by 125.64 percent. This is a 120.41 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $93.88 million which beat the analyst consensus estimate of $88.52 million by 6.05 percent. This is a 33.16 percent increase over sales of $70.50 million the same period last year.

Earnings Beats

IMCR

Immunocore Hldgs Q1 GAAP EPS $0.10 Beats $(0.39) Estimate, Sales $93.88M Beat $88.52M Estimate

Wells Fargo analyst Sarah Akers maintains ONE Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGS#NYSE">OGS</a>) with a Overweight and raises the price target from $82 to $89.

Wells Fargo Maintains Overweight on ONE Gas, Raises Price Target to $89

Former White House Communications Director Anthony Scaramucci has expressed concern over U.S. President Donald Trump's expanding involvement in the cryptocurrency industry, warning it could jeopardize bipartisan efforts to establish <a href="https://www.benzinga.com/government/regulations/25/04/45027836/sec-chair-paul-atkins-says-crypto-deserves-clear-regulatory-rules-praises-crypto-mom-hester-peirces-efforts">sound digital asset policies</a>.
What Happened: <a href="https://decrypt.co/318224/trump-crypto-businesses-pathways-corruption-scaramucci">Speaking</a> at the Financial Times Digital Asset Summit, Scaramucci criticized what he described as "distractions" posed by Trump-related crypto ventures, including a Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)-based meme coin, a stablecoin backed by his son Eric Trump, and multiple business partnerships with entities like Crypto.com.
He argued these ventures could potentially open "pathways for corruption, bribery, and other sinister behavior."
"Even if we give them the benefit of the doubt," Scaramucci said of the Trump family's crypto interests, "the presence of these ventures complicates efforts to build consensus in Washington, particularly with older legislators still skeptical about crypto."
Scaramucci acknowledged the Trump administration's overall performance in the crypto sector, giving it a &#8220;B-plus, A-minus&#8221; rating and praising <a href="https://www.benzinga.com/personal-finance/25/05/45185845/donald-trump-jr-s-new-private-social-club-counts-winklevoss-twins-crypto-czar-david-sacks-as-fou">crypto advisor</a> David Sacks for building bridges with Democratic lawmakers.
Still, he criticized Trump's executive order to establish a strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve, arguing that such unilateral action undermines long-term stability since a future administration could easily reverse it.
"What's needed is bipartisan commitment, not executive fiat," Scaramucci said, comparing Bitcoin's role in the U.S. economy to essential commodities like oil or rare earth metals.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45248407/rabbitx-founder-eyes-real-world-assets-and-liquidity-tokenization-as-the-future-of-perpetual-trading">RabbitX Founder Eyes Real-World Assets And Liquidity Tokenization As The Future Of Perpetual Trading</a>
Why It Matters: Democratic lawmakers have increasingly scrutinized Trump's crypto dealings, particularly following the announcement of an exclusive gala dinner for top holders of the Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) meme coin, a move that sent the coin's price soaring.
Senators Elizabeth Warren (D-Mass.) and Adam Schiff (D-CA) <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45187736/elizabeth-warren-slams-shady-deal-involving-trump-family-backed-usd1-as-democrats-withdraw-support-for-senarte-crypto-bill">warned that</a> the dinner could amount to "pay-to-play" politics by providing preferential access to the presidency in exchange for investment.
Warren has also flagged potential corruption linked to World Liberty Financial, a firm co-founded by Eric Trump. 
She cited a proposed $2 billion investment by Emirati firm MGX into Binance, to be settled using the firm's USD1 stablecoin, as raising serious red flags.
The mounting controversy has already disrupted legislative momentum. 
Democratic Senators recently blocked fast-tracking the <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45192914/us-stablecoin-legislation-will-transform-crypto-says-sui-foundations-christian-thompson">GENIUS Act</a>, a key piece of crypto legislation, while House Democrats led by Rep. Maxine Waters walked out of a digital assets hearing.
Waters voiced frustration at the influence of Trump's personal financial interests on policy progress. 
"We were close to passing a stablecoin bill," she said, "but Trump's brazen ownership of a crypto company, and using the presidency to attract investors, is unacceptable."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45248184/bitcoin-is-no-longer-just-digital-gold-native-staking-yield-are-redefining-its-role-says-core-dao">Bitcoin Is No Longer Just Digital Gold — Native Staking, Yield Are Redefining Its Role, Says Core DAO</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$SOL

$TRUMP

Anthony Scaramucci Gives Donald Trump 'B+ Or A-' On Crypto But Warns Presidential Meme Coin, DeFi Project Risk Derailing Policy Progress

Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) reported better-than-expected earnings for the <a href="https://www.benzinga.com/quote/alab/earnings">first quarter on Tuesday</a>.
The company posted quarterly earnings of 33 cents per share which beat the analyst consensus estimate of 28 cents per share. The company reported quarterly sales of $159.44 million which beat the analyst consensus estimate of $153.13 million.
&#8220;Astera Labs started the year strong, with Q1 revenue growing 13% sequentially and 144% year-over-year, and exceeding our first quarter guidance for gross margin and earnings per share,&#8221; said Jitendra Mohan, Astera Labs&#8217; Chief Executive Officer. &#8220;Our design wins across AI platforms, expanding portfolio with increasing value for customers, and significant traction with Scorpio fabric solutions strategically position us as a critical connectivity supplier for the entire AI rack. During the quarter, we saw strong demand for PCIe scale-up and Ethernet scale-out connectivity solutions in custom ASIC platforms, along with initial shipments for Scorpio P-Series and Aries 6 Retimers for merchant GPU-based platforms. These factors and new opportunities for scale-up interconnects boost our confidence in accelerating R&amp;D development to further strengthen our connectivity platform and to deliver results that outpace industry growth.&#8221;
Astera Labs said it sees second-quarter adjusted earnings of 32 cents to 33 cents per share, versus market estimates of 30 cents per share. The company expects sales of $170.000 million-$175.000 million versus estimates of $160.29 million.
Astera Labs shares dipped 5.4% to trade at $67.52 on Wednesday.
These analysts made changes to their price targets on Astera Labs following earnings announcement.
<ul>
<li>Barclays analyst Tom O&#8217;Malley maintained Astera Labs with an Overweight rating and raised the price target from $70 to $75.</li>
<li>Needham analyst Quinn Bolton maintained the stock with a Buy and lowered the price target from $140 to $100.</li>
</ul>
Considering buying ALAB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07093339/image-73-1024x572.png" alt="" class="wp-image-905689" style="width:641px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07093339/image-73-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07093339/image-73-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07093339/image-73-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07093339/image-73.png 1096w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Markets

ALAB

These Analysts Revise Their Forecasts On Astera Labs Following Q1 Results

Wells Fargo analyst Sarah Akers maintains Northwest Natural Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWN#NYSE">NWN</a>) with a Equal-Weight and raises the price target from $45 to $47.

Wells Fargo Maintains Equal-Weight on Northwest Natural Hldg, Raises Price Target to $47

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07090533/Three-Squirrels.jpeg" alt="" class="wp-image-12523" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07090533/Three-Squirrels.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07090533/Three-Squirrels-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/07090533/Three-Squirrels-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The snack food maker is joining a wave of companies listed on China's domestic A-share markets hoping to target global investors with second IPOs in Hong Kong
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>China's leading snack food maker Three Squirrels has filed for a Hong Kong IPO, with nut products accounting for over half of its revenue</li>
<li>The company is well placed in a highly fragmented domestic market where per-capita spending on snacks is significantly lower than in many developed countries</li>
</ul>
The intensifying trade war between China and the U.S. is hurting Chinese exporters, prompting Beijing to try to take up some of the slack by stimulating domestic demand. That's just fine for&nbsp;Three Squirrels Inc.&nbsp;(300783.SZ), whose snacks are already household names among many Chinese, as it looks to raise its global profile with a planned Hong Kong IPO. Such a move, disclosed in its&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2025/107311/documents/sehk25042504108.pdf">IPO filing</a>&nbsp;late last month, would complement the company's current listing in Shenzhen, making it China's first snack brand offering a bite of itself to both domestic and international investors.
The company was established in 2012 by Chairman and general manager Zhang Liaoyuan. It made a relatively steady, though perhaps not too exciting, living off its nuts and other snack foods in its early days, until its business was turbocharged by the internet more recently. By the time Three Squirrels listed on Shenzhen's Nasdaq-style ChiNext board in 2019, it had already grown into a giant with annual revenue of more than 10 billion yuan ($1.38 billion). Zhang remains the company's biggest shareholder with 42% of its shares.
<h4 class="wp-block-heading">Slow but steady growth</h4>
China's 1.4 billion mouths make its snack market full of potential, worth an estimated 1.08 trillion yuan in 2019 and growing by an average 4.4% each year to reach 1.34 trillion yuan by last year. With innovative new ideas constantly emerging and demand for healthy foods growing, the market is expected to hit 1.76 trillion yuan in value by 2029, growing around 5.5% annually over the next five years, according to third-party market data in the listing document.
Snack foods typically refer to small portions of packaged or bulk food consumed between meals, often as a quick bite. They are convenient, easy to eat and designed to satisfy hunger or cravings without the need for a full meal. They come in various categories, including nuts and seeds, crispy snacks and biscuits, confections and chocolates, baked snacks, meat and aquatic animal snacks, fruit snacks, seasoned flour products and children's snacks, among others.
At the top of the snack industrial chain are upstream suppliers of raw materials like agricultural and livestock products, condiments, food additives and packaging materials. The midstream includes brands, both Chinese and foreign. At the bottom of the snack food chain are downstream retailers and other channels that sell to final consumers over online or offline channels.
Three Squirrels is not only the biggest Chinese online snack company but also the biggest online seller in three major categories: nut products, baked snacks and meat snacks. The company has sold over 1,000 different products, known in the industry as standard product units or SPUs. Nut products were its best seller, accounting for more than half of its sales between 2022 and 2024. Three Squirrels sold 5.37 billion yuan worth of such products last year, accounting for 50.5% of its total revenue that year, up 40.8% year-on-year. They generated a gross profit of 1.29 billion yuan, up 46.3% year-on-year.
Those big gains lifted the company's total revenue by 49.3% last year to 10.62 billion yuan, while its profit rose 85.5% to 407 million yuan, showing nuts can be big business in China.
To keep the nut business growing, the company plans to invest 230 million yuan to add six new processing factories. Four will come on stream this year, with the other two joining next year. Those new facilities, combined with Three Squirrels' 22 existing production lines, will bring its total annual capacity to 63,500 tons of snacks.
<h4 class="wp-block-heading">Squirreling away for M&amp;A</h4>
While Three Squirrels is a relative heavyweight in its sector, China's overall snack industry is highly fragmented with minor brands taking up much of the market. The top five players accounted for just 5.9% of the market last year, while the top 10 took 10.4%. Despite its hefty market cap of over 10 billion yuan, Three Squirrels took just 1.04% of the market last year. It may be hoping to use some funds from its Hong Kong listing to bolster its position through M&amp;A to consolidate its position.
While M&amp;A offers strong potential, the China snack market also holds out room for growth due to the country's relatively low per-capita spending on snacks. According to a Ping An Securities report, the average Chinese spends just $87 per year on snacks, a tiny fraction of the $400 for Americans, $328 for British consumers, and $287 and $228 for Japanese and South Koreans, respectively. That suggests big room for further growth as Chinese consumers catch up with their peers in developed countries.
Three Squirrels is notable for its unique marketing strategies. Those include a series of self-produced TV shows, short videos, theme songs and interactive events with the company's namesake Three Squirrels at the forefront to promote its brand image and deepen its connection with consumers. It also offers specialty brand products to further enhance its profile and uses an "entertainment strategy" complete with brand IP, product placements and derivative products to engage more closely with consumers.
As Chinese consumers become more health-conscious, the company also rolled out its Deer Blue brand in 2020 targeting infants, with the goal of providing them with healthy food and snacks. However, the brand itself is still in its infancy, accounting for just 7.5% of the company's sales last year. The Three Squirrels brand still remains the king of the company's roost, accounting for 92.5% of last year's sales.
Analysts expect the company's profit to grow more than 40% again this year to 576 million yuan. Its Shenzhen-listed shares currently trade at a forward price-to-earnings (P/E) ratio of 21 times, higher than the 18 times for international peer&nbsp;Calbee&nbsp;(2229.T). Hong Kong investors typically value stocks at lower multiples than their Chinese peers. But with its strong growth and potential to emerge as a consolidator in China's huge snack market, it's possible Three Squirrels could defy the odds and seek a valuation for its Hong Kong stock similar to its Shenzhen valuation.

Asia

Equities

IPOs

Opinion

Another Chinese Firm Eyeing Second IPO In Hong Kong To Attract Global Investors

Wells Fargo analyst Sarah Akers maintains New Jersey Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NJR#NYSE">NJR</a>) with a Equal-Weight and raises the price target from $51 to $53.

Wells Fargo Maintains Equal-Weight on New Jersey Resources, Raises Price Target to $53

<a href="https://muddywatersresearch.com/research/2025/app-persistent-lies/" title="https://muddywatersresearch.com/research/2025/app-persistent-lies/">https://muddywatersresearch.com/research/2025/app-persistent-lies/</a>

Short Sellers

Trading Ideas

Watcing AppLovin; Muddy Waters Research Issues Report On Co, Stating It Is Short

Health Care

Press Releases

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January

General

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference

Comments

Molecular Partners

Vendite allo scoperto

Molecular Partners (NASDAQ:MOLN) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO